Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Dauntless who wrote (6032)	12/30/1998 12:34:00 PM
From: Hank	Respond to of 7041

I can say none was sold because it doesn't take an entire quarter to put a new product on a pharmacist's shelves. If SGP had bought 167K worth of Vasoscam in the second quarter to sell in Mexico, then there should have been SOME sales in 3Q. The 10Q specifically says that that there were no sales in 3Q. When Pfizer got approval for Viagra in the US, how long do you think it took them to get the product to market? About a week. If SGP unloaded 167K worth of Vasoscam in Mexico this year, it was as free samples to Dr's because they sure as hell didn't sell any.

To: Dauntless who wrote (6032)	12/30/1998 1:14:00 PM
From: Hank	Read Replies (1) \| Respond to of 7041

Oh, and just one more point Duantless. Before you and others begin your witty personal attacks on me, I would suggest that anyone interested in ZONA go back and check the posting history of this thread. You will find out who knows what they are talking about and who doesn't. For example, I warned the omniscient ZONA bulls on this thread many, many months ago that a quick approval of Vasoscam by the FDA would not occur due to potential drug interaction problems. At that time, I suggested that the FDA would ultimately stall the Vasoscam review process by forcing ZONA to undergo additional clinical trials to determine if it was safe to use with certain other prescription drugs, particularly cardiovascular drugs. My predictions were immediately attacked and discounted by the so called "experts" on this thread (Remember Duantless?). They even went so far as to pour over FDA publications in order to "prove" to me that such tests were not required for FDA approval. The only problem is that none of these so called "experts" knows a damn thing about how the pharmaceutical industry works. They have never been employed by the pharmaceutical industry. I have. Now it appears that my prediction has come true (note Linda's post #6007). If the people who read this thread want to buy ZONA stock based on what people like Duantless and others have to say here, then they deserve to lose their money.